SCHEMBL3847045

SCHEMBL3847045

Fc1ccc(-c2onc3ccc(-c4cnn(C(c5ccccc5)(c5ccccc5)C5C=CC=CC5)c4)cc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
KDM4E B2RXH2 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
LMNA P02545 2/20 0.37
PABPC1 P11940 1/20 0.37
ALDH1A1 P00352 6/20 0.36
HPGD P15428 1/20 0.33
IP6K1 Q92551 9/20 0.33
IP6K3 Q96PC2 7/20 0.33
IP6K2 Q9UHH9 7/20 0.33
PIM1 P11309 1/20 0.33
TSHR P16473 2/20 0.32
TP53 P04637 2/20 0.32
HSD17B10 Q99714 2/20 0.32
NPC1 O15118 2/20 0.32
POLB P06746 1/20 0.32
USP2 O75604 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846131 0.85 MEN1 (0.38) MEN1KMT2AKDM4ESMN1; SMN2LMNA
SCHEMBL3852914 0.84 MEN1 (0.38) MEN1KMT2AKDM4ESMN1; SMN2LMNA
SCHEMBL3847041 0.81 MEN1 (0.46) MEN1KMT2AKDM4ESMN1; SMN2LMNA
SCHEMBL3846777 0.79 ATM (0.36) ALDH1A1HPGDMAPK1MAPK10
SCHEMBL3846738 0.73 ACHE (0.39) MEN1KMT2AKDM4ESMN1; SMN2LMNA
SCHEMBL3845226 0.73 PIK3CD (0.32)
SCHEMBL3846526 0.73 MAPKAPK2 (0.39) MEN1KMT2ALMNAALDH1A1USP2
SCHEMBL3846797 0.73 CYP3A4 (0.49) MEN1KMT2AKDM4ESMN1; SMN2LMNA
SCHEMBL3846403 0.72 LRRK2 (0.31)
SCHEMBL3850389 0.71 MAPKAPK2 (0.39) SMN1; SMN2ALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed